Literature DB >> 24333311

Clinical use of polyvalent immunoglobulins.

Isabella Quinti1, Anna Maria Pesce1, Livia Bonanni1, Carlotta Rubino1, Federica Pulvirenti1, Cinzia Milito1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333311      PMCID： PMC3853978          DOI： 10.2450/2013.007s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  33 in total

1.  Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.

Authors:  Vincent R Bonagura; Robert Marchlewski; Amanda Cox; David W Rosenthal
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

2.  Guidelines on the use of high-dose intravenous immunoglobulin in dermatology.

Authors:  Alexander Enk
Journal:  Eur J Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.328

3.  Prescribing intravenous immunoglobulin: summary of Department of Health guidelines.

Authors:  Drew Provan; Helen M Chapel; W A Carrock Sewell; Denise O'Shaughnessy
Journal:  BMJ       Date:  2008-10-20

4.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

Review 5.  Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.

Authors:  Domenico De Mattia; Giovanni Carlo Del Vecchio; Giovanna Russo; Attilio De Santis; Ugo Ramenghi; Lucia Notarangelo; Momcilo Jankovic; Angelo Claudio Molinari; Marco Zecca; Bruno Nobili; Paola Giordano
Journal:  Acta Haematol       Date:  2009-12-23       Impact factor: 2.195

Review 6.  Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.

Authors:  Sven G Meuth; Christoph Kleinschnitz
Journal:  Eur Neurol       Date:  2010-02-11       Impact factor: 1.710

Review 7.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

Review 8.  Primary immunodeficiencies.

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793

Review 9.  Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.

Authors:  Pia Raanani; Anat Gafter-Gvili; Mical Paul; Isaac Ben-Bassat; Leonard Leibovici; Ofer Shpilberg
Journal:  Leuk Lymphoma       Date:  2009-05

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542
View more
  4 in total

1.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 3.  The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.

Authors:  Albert Farrugia; Giuliano Grazzini; Isabella Quinti; Fabio Candura; Samantha Profili; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

4.  Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection.

Authors:  Gerard Solís-Díez; Marta Turu-Pedrola; Marta Roig-Izquierdo; Corinne Zara; Antoni Vallano; Caridad Pontes
Journal:  Front Public Health       Date:  2022-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.